Blood tests can identify anemia, pregnancy, thyroid disease, inflammation, and other conditions that resemble endometriosis—but none can prove endometriosis by itself. The most useful testing plan combines symptom history, examination, targeted labs, and expert imaging.
- No single blood test can diagnose or exclude endometriosis, including a normal CA-125 result.
- CA-125 may rise above a laboratory upper limit of roughly 35 U/mL in endometriosis, but it also rises with periods, fibroids, pregnancy, pelvic infection, and many non-cancerous conditions.
- kompleta sangokalkulado kaj ferritino can detect iron deficiency from heavy menstrual bleeding; ferritin below 15 ng/mL strongly supports depleted iron stores in otherwise well adults.
- gravedeca testado is urgent for new pelvic pain with a missed period because ectopic pregnancy needs prompt assessment.
- Transvaginal ultrasound can identify ovarian endometriomas and deep disease in experienced hands, but a normal scan does not rule out superficial endometriosis.
- MRI is most useful for mapping suspected deep endometriosis before complex treatment, rather than as a universal first test.
- Laparoscopy is considered when symptoms persist, imaging is negative or unclear, and empirical treatment is unsuccessful, unsuitable, or declined.
- Symptom timing matters: cyclical bowel pain, pain with sex, infertility, and pain that starts before menstruation raise clinical suspicion even when routine laboratory results are normal.
Can a blood test diagnose endometriosis?
No endometriosis blood test can diagnose the condition on its own as of September 21, 2026. CA-125 and other endometriosis blood markers may support a clinical picture or identify consequences such as iron deficiency, but they cannot reliably distinguish endometriosis from common look-alikes.
Endometriosis is tissue resembling the uterine lining growing outside its usual location, and small superficial deposits often release too little measurable material into circulation for a dependable serum test. A normal result therefore does not mean that pain is imagined or that endometriosis is absent. This is a major reason diagnosis has historically taken years.
In my clinical experience, the misleading reassurance often comes from a completely normal full blood count and CRP. Those results can be reassuring in a different sense—they make severe anemia, major systemic inflammation, or acute infection less likely—but they do not test for pelvic endometriosis.
Thomas Klein, MD, advises treating laboratory data as one layer of evidence: symptom pattern, pelvic examination, ultrasound quality, fertility goals, and response to treatment usually matter more than one marker. Our gvidilo pri sangaj biomarkiloj can help patients understand what a named result measures before a clinical appointment.
Why a simple marker remains elusive
A useful screening marker needs both high sensitivity and high specificity; endometriosis biomarkers have generally failed one or both tests across menstrual-cycle phases and disease subtypes. The Cochrane review by Nisenblat et al. (2016) concluded that no blood biomarker had sufficient accuracy to replace surgery or imaging in routine diagnosis.
CA-125 for endometriosis: useful context, not proof
CA-125 is not a diagnostic test for endometriosis. A value above about 35 U/mL may occur with moderate or extensive disease, especially ovarian endometriomas, yet many people with confirmed endometriosis have values within their laboratory range.
CA-125 is a protein released from several tissues, including the lining of the abdomen and chest; it is not made exclusively by endometriosis. Menstruation, adenomyosis, fibroids, benign ovarian cysts, pregnancy, liver disease, pelvic infection, and some cancers can elevate it. A result of 48 U/mL during a heavy period has a very different meaning from the same result after menopause.
Timing is an underused detail. If a clinician chooses CA-125 for a particular reason, drawing it during menstruation can make interpretation noisier; repeating an unexpected mild elevation after the period has finished is often more informative than reacting to a single number. For a focused discussion of a raised result, see our guide to kiam CA-125 estas alta.
Kantesti estas AI-sangotesta analizilo that places CA-125 alongside the reference interval, age, reported cycle context, and related laboratory findings; it does not label a person as having endometriosis from CA-125 alone. A rising CA-125 trend also cannot determine the cause without clinical review.
Other endometriosis blood markers under study
No alternative blood marker—including cytokines, microRNAs, CA 19-9, or HE4—has enough validated accuracy for routine endometriosis diagnosis. Research signals are interesting, but a commercially available result should not replace specialist assessment.
Researchers have studied interleukin-6, CA 19-9, microRNAs, circulating endometrial cells, and panels of proteins because endometriosis has immune and inflammatory features. The trouble is biological overlap: the same markers shift with a viral illness, higher body weight, adenomyosis, autoimmune disease, normal ovulation, and sample-handling differences.
HE4 is sometimes ordered alongside CA-125 when an adnexal mass needs risk assessment, not to diagnose endometriosis. Kidney function can raise HE4 independently, which is why an abnormal result should be read with creatinine and eGFR; our explanation of HE4 result limits covers that pitfall.
A multi-marker panel may eventually improve triage, particularly if it includes symptoms and imaging features rather than serum chemistry alone. For now, a test marketed as definitive deserves a careful question: what independent study compared it against expert imaging or surgically confirmed disease, and in which patient population?
Blood tests that help rule out similar conditions
Blood tests help most by finding conditions that mimic or coexist with endometriosis. The initial panel is selected by symptoms: pregnancy test for delayed periods, CBC and ferritin for heavy bleeding, thyroid tests for cycle change, and targeted inflammation or coeliac testing when history points there.
A urine or serum hCG test is the first safety test for reproductive-age patients with pelvic pain, delayed bleeding, or unexpected spotting. A negative urine test is usually reliable from the expected period onward, but a quantitative serum hCG may be used when timing is uncertain or clinicians need to assess possible ectopic pregnancy.
TSH is reasonable when fatigue, constipation, hair change, weight change, or unusual cycle spacing suggests thyroid disease. Most adult laboratories use a TSH reference interval around 0.4-4.0 mIU/L, though pregnancy-specific targets are lower and results must be interpreted with free T4 when abnormal; see our guide to subklinika hipotiroidismo.
CRP and ESR are not endometriosis tests. A CRP above 10 mg/L can reflect many processes, but fever, escalating pain, high CRP, and neutrophilia should shift attention toward acute infection or another urgent abdominal cause rather than assuming a routine endometriosis flare.
CBC and iron studies when periods are heavy
A CBC and ferritin test can detect iron depletion caused by heavy menstrual bleeding, a frequent consequence of adenomyosis, fibroids, or endometriosis-associated bleeding. Ferritin below 15 ng/mL strongly supports iron deficiency in a person without major inflammation, even before hemoglobin falls.
Hemoglobin below 120 g/L in a non-pregnant adult woman meets the World Health Organization definition of anemia, although symptoms such as breathlessness and reduced exercise tolerance can appear with ferritin depletion first. Mean corpuscular volume may remain normal early on, so a normal MCV does not clear iron stores.
Ferritin is also an acute-phase reactant. In someone with raised CRP, a ferritin of 30 ng/mL can still be compatible with iron deficiency, and transferrin saturation below 20% adds useful evidence. The combination—not a single borderline ferritin—is what I look for in practice.
Kantesti AI interprets CBC, ferritin, serum iron, transferrin saturation, and CRP as a pattern, helping users prepare concise questions for their clinician. Our articles on malalta feritino antaŭ anemio kaj signoj de peza menstrua sangado explain when fatigue or bleeding needs more timely care.
When bowel symptoms change the testing plan
Cyclical bowel pain can occur with endometriosis, but persistent diarrhea, rectal bleeding, weight loss, or raised inflammatory markers should prompt evaluation for bowel disease as well. Stool tests often outperform blood tests when inflammatory bowel disease is a concern.
Fecal calprotectin below 50 micrograms/g in adults makes active inflammatory bowel disease less likely, while a value above 250 micrograms/g usually warrants more direct gastrointestinal assessment. Endometriosis alone does not reliably cause high fecal calprotectin, which is clinically helpful when symptoms overlap.
Coeliac serology, typically tissue transglutaminase IgA with total IgA, is reasonable for persistent diarrhea, bloating, iron deficiency, or a family history of coeliac disease. Testing while still eating gluten matters; removing gluten first can create a false-negative result. Our guide to a gluten challenge before coeliac tests klarigas la tempon-teman problemon.
The ESHRE guideline notes that symptoms alone cannot reliably locate endometriosis, especially when bowel symptoms dominate (Becker et al., 2022). In my experience, the pattern of pain worsening predictably in the days before menstruation is informative, but it never cancels red flags such as visible blood in stool or unintentional 5% weight loss.
When ultrasound helps with endometriosis diagnosis
A specialist transvaginal ultrasound can identify ovarian endometriomas and many deep endometriosis features, but a normal ultrasound does not exclude superficial disease. The clinician's training and the requested protocol often matter more than the machine model.
Endometriomas often have a characteristic internal appearance on ultrasound, and experienced operators can assess mobility of pelvic structures, tenderness mapping, and signs of deep disease. A standard scan performed for general pelvic symptoms may not include this focused assessment, so asking whether the service evaluates for deep endometriosis is sensible.
Ultrasound is also excellent for finding look-alikes: fibroids, adenomyosis features, hydrosalpinx, and ovarian cysts. It cannot see every cause of pain, and it cannot reliably rule out tiny superficial deposits; a report saying "normal" should be read as "no abnormality seen on this examination," not "endometriosis excluded."
For patients comparing tests, Thomas Klein, MD, recommends recording cycle day, hormonal contraception, and the exact pain location before the scan. This brief context improves the referral question more than repeating non-specific inflammatory blood markers.
When MRI is the right next test
MRI is most useful when clinicians suspect deep endometriosis, need a map before specialist treatment, or have an ultrasound result that does not explain significant symptoms. MRI is not routinely needed for every person with painful periods.
MRI can evaluate areas that are hard to characterize by ultrasound and can help surgical teams anticipate involvement near bowel, bladder, nerves, or other deep pelvic structures. Preparation protocols differ: some centers use bowel preparation or antispasmodic medication, while others do not, so follow local instructions rather than copying advice from a forum.
A negative MRI does not exclude superficial endometriosis, just as a negative ultrasound does not. The 2022 ESHRE guideline recommends imaging in the diagnostic work-up while emphasizing that negative imaging cannot rule out the disease (Becker et al., 2022).
If an MRI report contains unfamiliar terms, compare it with symptoms and previous scans instead of searching each phrase in isolation. Our women's health testing guide may help organize the reproductive-health questions worth bringing to a specialist.
When laparoscopy is considered
Laparoscopy is considered when symptoms remain clinically significant and imaging is negative, uncertain, or insufficient for a treatment decision. It can directly inspect pelvic surfaces and may allow treatment during the same procedure, but it is not automatically the first step.
The decision depends on pain severity, fertility plans, prior operations, the likelihood of deep disease, and whether hormonal treatment is acceptable. ESHRE moved away from calling laparoscopy the universal diagnostic gold standard because expert imaging plus symptom-guided treatment is appropriate for many patients.
A procedure can miss disease if lesions are subtle, inaccessible, or not recognized, and pathology confirmation depends on what is sampled. Conversely, finding a small area of endometriosis does not prove it explains every symptom; coexisting pelvic floor dysfunction, irritable bowel syndrome, and bladder pain can amplify pain.
A useful pre-operative question is: "What result would change our plan?" That question exposes whether surgery is being considered for diagnosis, treatment, fertility planning, or exclusion of an alternative problem—and those are not interchangeable goals.
Symptoms that raise suspicion despite normal labs
Normal routine blood work does not outweigh a classic endometriosis symptom pattern. Pain beginning before menstruation, pain during sex, cyclical pain with bowel movements or urination, infertility, and a family history together deserve a structured assessment.
The timing of pain is often more diagnostic than its intensity score. I have seen patients describe a 7-day arc: deep pelvic ache 48 hours before bleeding, bowel pain on days 1 to 3, then gradual relief. That repeatable arc is more informative than a CRP of 2 mg/L.
Painful periods are common, but a change from manageable cramps to pain that causes missed work, vomiting, faintness, or escalating use of analgesia warrants evaluation. Symptoms can begin in adolescence, and clinicians should not assume severe pain is normal simply because a pelvic examination is unremarkable.
Kantesti estas AI sangotesta interpretada platformo that can preserve longitudinal lab context while users track symptoms separately; blood results cannot quantify pain or replace examination. For unexplained persistent pain, our overview of sangokontroloj por neklarigita doloro outlines sensible laboratory boundaries.
Do hormone tests diagnose endometriosis?
Estradiol, progesterone, LH, FSH, AMH, and testosterone tests do not diagnose endometriosis. They can be useful for a separate question—ovulation, ovarian reserve, menopause, PCOS, or fertility planning—when timed and interpreted correctly.
Estradiol and progesterone change substantially across a 28-day cycle, so an isolated value without cycle day has limited meaning. A progesterone level drawn about 7 days after ovulation can support recent ovulation, but the correct day varies with cycle length and ovulation timing.
AMH estimates ovarian reserve rather than egg quality and does not diagnose endometriosis. Ovarian endometriomas and ovarian surgery can affect reserve, which makes AMH potentially relevant in fertility counseling but not in deciding whether pain represents endometriosis.
People stopping hormonal contraception often receive broad hormone panels too soon. If the clinical aim is to investigate PCOS or a cycle disorder, our guide to PCOS blood tests after contraception La buŝa glukozelteniva testo kaj hazarda glukozo estas la decidantoj, kiam fastanta glukozo aŭ HbA1c maltrafas la rakonton.
Testing when endometriosis and fertility overlap
Endometriosis can affect fertility, but no blood marker can tell whether it is the cause for an individual couple. Fertility assessment usually combines ovulation history, semen analysis, tubal assessment when indicated, ultrasound, and an individualized endometriosis evaluation.
For people under 35, infertility is usually defined as 12 months of unprotected intercourse without pregnancy; for those aged 35 or older, assessment commonly starts after 6 months. Earlier referral is appropriate with absent periods, known tubal disease, prior pelvic surgery, severe symptoms, or a partner with known fertility concerns.
AMH can help plan fertility treatment but should not be used as a yes-or-no fertility test. A low AMH result may predict fewer eggs retrieved during stimulation, while spontaneous conception remains possible; our article on low AMH causes and timing gives the nuance many reports omit.
A normal semen analysis does not rule out female-factor infertility, and normal female hormone tests do not rule out endometriosis. The value of a consultation is integration—two individually "normal" work-ups can still point to a coherent next step.
A practical testing plan for suspected endometriosis
The best next test depends on the symptom that needs an answer first. For most patients, a pregnancy test when relevant, CBC and ferritin for heavy bleeding, a focused pelvic ultrasound, and referral to an endometriosis-aware clinician form a more useful starting plan than a broad biomarker panel.
Bring a 2- to 3-cycle diary that notes bleeding volume, pain location, bowel and urinary symptoms, pain with sex, missed activities, medication doses, and whether symptoms are cyclical. Include prior imaging reports and the actual laboratory numbers rather than only flags; reference intervals vary by laboratory.
Kantesti estas AI-movita ilo por analizo de sangotestoj that can organize CBC, iron, thyroid, and other available results in roughly 60 seconds, but its output is educational support rather than a diagnosis or treatment plan. Users should verify unusual results with the reporting laboratory and discuss them with their treating clinician.
For a safe handoff, make a one-page list of questions: What alternatives are still plausible? Was the ultrasound tailored to endometriosis? Is MRI likely to change management? What are the advantages and downsides of empirical treatment versus laparoscopy? Our kontrolilon pri precizeco de AI-rezulto is useful before sharing a report.
When pelvic pain needs urgent medical care
Sudden severe pelvic or abdominal pain, fainting, shoulder-tip pain, fever, persistent vomiting, a positive pregnancy test, or very heavy bleeding requires urgent assessment rather than an endometriosis blood test. These symptoms can signal ectopic pregnancy, ovarian torsion, appendicitis, serious infection, or significant blood loss.
Seek emergency care for soaking a pad or tampon every hour for 2 consecutive hours, passing large clots with dizziness, or feeling faint. A hemoglobin result can lag behind sudden volume loss, so clinicians assess pulse, blood pressure, symptoms, examination findings, and repeat testing when needed.
Fever of 38.0°C or above with worsening pelvic pain is not typical evidence of routine endometriosis alone. Acute symptoms may require pregnancy testing, urinalysis, CBC, CRP, ultrasound, and sometimes cross-sectional imaging on the same day; our guide to urinalysis versus urine culture explains one common branch of that work-up.
Kantesti's medical content is reviewed against clinical standards, but emergencies belong with local urgent-care services, not online interpretation. Readers can learn how our clinical governance is assessed through our medicina validiga kadro kaj renkonti la kuracistojn ĉe nia Medicina Konsila Komisiono.
Oftaj Demandoj
Ĉu CA-125 povas diagnozi endometriozon?
CA-125 ne povas diagnozi endometriozon ĉar ĝi ne estas specifa por tiu malsano. Multaj laboratorioj uzas supran referencan limon proksime de 35 U/mL, sed endometriozo, menstruo, fibromoj, adenomiozo, gravedeco, pelva infekto, hepata malsano kaj iuj kanceroj povas ĉiuj pliigi ĝin. Normala CA-125 rezulto ankaŭ okazas ĉe multaj homoj kun kirurgie konfirmita endometriozo. Klinikistoj uzas CA-125 nur kiel kuntekstan informon, neniam kiel memstaran jes-aŭ-ne teston.
Ĉu endometriozoj povas kaŭzi nenormalajn sangokontrolojn?
Endometriozo ofte kaŭzas tute normalajn rutinajn sangosondojn, precipe kiam la malsano estas supraĵa. Peza menstrua sangado povas konduki al fera manko, kun feritino sub 15 ng/mL forte subtenanta elĉerpitajn ferostokojn kiam inflamo forestas, kaj hemoglobino sub 120 g/L kontentigante la kutiman sojlon de anemio por ne-gravedaj plenkreskaj virinoj. CRP kaj ESR povas esti normalaj aŭ modere altigitaj, sed nek testo diagnozas endometriozon. Nenormalaj rezultoj devus gvidi serĉon pri komplikaĵoj aŭ alternativaj kondiĉoj prefere ol esti traktataj kiel pruvo de endometriozo.
Kio estas la plej bona testo por endometriozo?
Ne ekzistas ununura plej bona testo por ĉiu prezento de endometriozoj. Spertula transvaginala ultrasonografio ofte estas la unua bildiga testo ĉar ĝi povas identigi ovariajn endometriomojn kaj signojn de profunda malsano, dum MR povas helpi mapi suspektitan profundan malsanon antaŭ specialisttraktado. Normala bildigo ne ekskludas surfacan endometriozon. Laparoskopio estas konsiderata kiam simptomoj restas signifaj kaj ne-invada taksado ne provizas taŭgan respondon aŭ traktovojon.
Can a normal ultrasound rule out endometriosis?
A normal ultrasound cannot rule out endometriosis because small superficial deposits may not be visible. Ultrasound is more accurate for ovarian endometriomas and some deep endometriosis patterns when performed by an operator trained in focused pelvic assessment. The 2022 ESHRE guideline states that negative imaging does not exclude endometriosis. Persistent cyclical symptoms therefore merit follow-up even after a normal scan.
Should I get hormone tests for suspected endometriosis?
Hormone tests such as estradiol, progesterone, LH, FSH, and AMH do not diagnose endometriosis. They may be useful when a clinician is evaluating ovulation, ovarian reserve, menopause, PCOS, or infertility alongside suspected endometriosis. Progesterone is usually most meaningful about 7 days after ovulation, not on a fixed calendar day for every person. Results must be interpreted with cycle timing and hormonal medication use.
When should pelvic pain be treated as an emergency?
Sudden severe pelvic pain with fainting, shoulder-tip pain, fever of 38.0°C or above, persistent vomiting, a positive pregnancy test, or very heavy bleeding needs urgent medical assessment. Soaking a pad or tampon every hour for 2 consecutive hours, especially with dizziness or weakness, is a practical threshold for prompt care. These symptoms may indicate ectopic pregnancy, ovarian torsion, appendicitis, infection, or significant blood loss rather than a routine endometriosis flare. Do not wait for CA-125 or other outpatient blood results in that situation.
Akiru hodiaŭ AI-movitan analizon de sangoanalizo
Aliĝu al pli ol 2 milionoj da uzantoj tutmonde, kiuj fidas je Kantesti por tuja, preciza analizo de laboratoriaj testoj. Alŝutu viajn rezultojn de sangoanalizo kaj ricevu ampleksan interpretadon de 15,000+-biomarkiloj en sekundoj.
📚 Referencitaj esplorpublikaĵoj
Klein, T., Mitchell, S., & Weber, H. (2026). Kantesti LTD. (2026). A Pre-Registered, Rubric-Based Automated Technical Benchmark of the Kantesti Blood-Test Interpretation Engine on 100,000 Synthetic Test Cases. Figshare. ResearchGate: https://www.researchgate.net/ Academia.edu: https://www.academia.edu/. Kantesti AI Medicina Esploro.
Klein, T., Mitchell, S., & Weber, H. (2026). Kantesti LTD. (2026). Clinical Validation Framework v2.0 (Medical Validation Page). Zenodo. ResearchGate: https://www.researchgate.net/ Academia.edu: https://www.academia.edu/. Kantesti AI Medicina Esploro.
📖 Eksteraj medicinaj referencoj
⚕️ Medicina Deklaro
Ĉi tiu artikolo estas nur por edukaj celoj kaj ne konsistigas medicinan konsilon. Ĉiam konsultu kvalifikitan sanprovizanton por diagnozaj kaj traktadaj decidoj.
Signaloj de fido E-E-A-T
Sperto
Kuracista gvidata klinika revizio de laboratoriaj interpretaj laborfluoj.
Kompetenteco
Laboratoria medicino fokusiĝas pri kiel biomarkiloj kondutas en klinika kunteksto.
Aŭtoritateco
Skribita de d-ro Thomas Klein kun revizio de d-ro Sarah Mitchell kaj prof. d-ro Hans Weber.
Fidindeco
Evident-bazita interpretado kun klaraj sekvaj vojoj por redukti alarmon.